We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Rexahn Pharmaceuticals Inc | NASDAQ:REXN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.81 | 1.75 | 1.83 | 0 | 01:00:00 |
Delaware
|
001-34079 |
11-3516358
|
||
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
37000 Grand River Avenue, Suite 120
Farmington Hills,
MI
|
48335 | |
(Address of principal executive offices)
|
(Zip Code)
|
N/A
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.0001 par value
|
OCUP |
|
Item 5.07. |
Submission of Matters to a Vote of Security Holders.
|
Nominee
|
Votes For
|
Votes Withheld
|
Broker Non-Votes
|
|||
Cam Gallagher
|
4,488,270
|
1,652,200
|
5,087,873
|
|||
Sean Ainsworth
|
5,370,425
|
770,045
|
5,087,873
|
|||
James Manuso
|
5,318,419
|
822,051
|
5,087,873
|
|||
Richard Rodgers
|
4,538,415
|
1,602,054
|
5,087,873
|
|||
Susan Benton
|
5,351,488
|
788,982
|
5,087,873
|
|||
Jay Pepose
|
5,314,552
|
825,918
|
5,087,873
|
Votes For
|
Votes Against
|
Votes Abstain
|
||
11,172,192
|
19,672
|
36,479
|
One Year
|
Two Years
|
Three Years
|
Votes Abstain
|
|||
4,180,454
|
293,529
|
1,447,777
|
218,710
|
OCUPHIRE PHARMA, INC.
|
||
By:
|
/s/ Richard Rodgers
|
|
Richard Rodgers
|
||
Interim President and Chief Executive Officer
|
||
Date: June 8, 2023
|
1 Year Rexahn Pharmaceuticals Chart |
1 Month Rexahn Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions